GTAB B — Glycorex Transplantation AB (publ) Share Price
Last trade - 00:00- SEK147.71m
- SEK147.94m
- SEK35.16m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.46 | ||
| Price to Tang. Book | 10.58 | ||
| Price to Free Cashflow | 1,462.46 | ||
| Price to Sales | 4.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.91% | ||
| Return on Equity | -28.36% | ||
| Operating Margin | -29.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 27 | 28.2 | 36.12 | 29.96 | 35.16 | n/a | n/a | -0.53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Glycorex Transplantation AB (publ) is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. The Company’s medical devices enable transplants across the blood groups saving lives and providing health economic benefits by increasing the number of transplants.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 13th, 1995
- Public Since
- July 6th, 1998
- No. of Employees
- 21
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Nordic Growth Market - Stockholm
- Shares in Issue
- 73,853,983
- Address
- Scheelevagen 27, LUND, 223 63
- Web
- https://glycorex.com/
- Phone
- +46 462865230
- Auditors
- Ernst & Young AB
Upcoming Events for GTAB B
Similar to GTAB B
ATTANA AB
Nordic Growth Market - Stockholm
Coegin Pharma AB
Nordic Growth Market - Stockholm
Diagonal Bio AB
Nordic Growth Market - Stockholm
Lumito AB (publ)
Nordic Growth Market - Stockholm
Lumito AB (publ)
Nordic Growth Market - Stockholm
FAQ
As of Today at 20:52 UTC, shares in Glycorex Transplantation AB (publ) are trading at SEK2.00. This share price information is delayed by 15 minutes.
Shares in Glycorex Transplantation AB (publ) last closed at SEK2.00 and the price had moved by +86.92% over the past 365 days. In terms of relative price strength the Glycorex Transplantation AB (publ) share price has outperformed the FTSE Global All Cap Index by +82.24% over the past year.
There is no consensus recommendation for this security.
Find out moreGlycorex Transplantation AB (publ) does not currently pay a dividend.
Glycorex Transplantation AB (publ) does not currently pay a dividend.
Glycorex Transplantation AB (publ) does not currently pay a dividend.
To buy shares in Glycorex Transplantation AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK2.00, shares in Glycorex Transplantation AB (publ) had a market capitalisation of SEK147.71m.
Here are the trading details for Glycorex Transplantation AB (publ):
- Country of listing: Sweden
- Exchange: NGM
- Ticker Symbol: GTAB B
Based on an overall assessment of its quality, value and momentum Glycorex Transplantation AB (publ) is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Glycorex Transplantation AB (publ). Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +18.19%.
As of the last closing price of SEK2.00, shares in Glycorex Transplantation AB (publ) were trading +6.42% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Glycorex Transplantation AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Glycorex Transplantation AB (publ)'s management team is headed by:
- Johan Nilsson - CEO
- Kurt Nilsson - DCE
- Kerstin Jakobsson - IND